Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Paul Hopper has increased his stake in Chimeric Therapeutics Limited to 12.4%, up from 10.5%, following participation in a recent placement. This move signifies a growing confidence in the company’s potential, attracting the attention of investors keen on market dynamics and strategic investments in the biotechnology sector.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.